These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 7107390

  • 1. Enhancement of cytotoxic drugs by misonidazole (MISO) in Lewis lung tumors of different sizes, and mouse bone marrow.
    Spooner D, Peacock JH, Stephens TC.
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):643-6. PubMed ID: 7107390
    [Abstract] [Full Text] [Related]

  • 2. Chemosensitization of mouse tumors by misonidazole.
    Randhawa VS, Stewart FA, Denekamp J.
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):671-4. PubMed ID: 7107397
    [Abstract] [Full Text] [Related]

  • 3. Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole.
    Stephens TC, Courtenay VD, Mills J, Peacock JH, Rose CM, Spooner D.
    Br J Cancer; 1981 Apr; 43(4):451-7. PubMed ID: 7236488
    [Abstract] [Full Text] [Related]

  • 4. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P, Workman P.
    Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
    [Abstract] [Full Text] [Related]

  • 5. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
    Clutterbuck RD, Millar JL, McElwain TJ.
    Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
    [Abstract] [Full Text] [Related]

  • 6. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity.
    Hirst DG, Brown JM.
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(3-4):639-42. PubMed ID: 7107389
    [Abstract] [Full Text] [Related]

  • 7. Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
    Roizin-Towle LA, Hall EJ.
    Br J Cancer; 1981 Aug; 44(2):201-7. PubMed ID: 6168277
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
    Hirst DG, Brown JM, Hazlehurst JL.
    Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845
    [Abstract] [Full Text] [Related]

  • 9. The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse.
    Hinchliffe M, McNally NJ, Stratford MR.
    Br J Cancer; 1983 Sep; 48(3):375-83. PubMed ID: 6615699
    [Abstract] [Full Text] [Related]

  • 10. An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.
    Twentyman PR, Workman P.
    Br J Cancer; 1983 Feb; 47(2):187-94. PubMed ID: 6824566
    [Abstract] [Full Text] [Related]

  • 11. Azomycin riboside: a new radiosensitizer.
    Pedersen JE, Barron G, Chapman JD.
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(3-4):415-8. PubMed ID: 7107360
    [Abstract] [Full Text] [Related]

  • 12. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
    Law MP, Hirst DG, Brown JM.
    Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
    [Abstract] [Full Text] [Related]

  • 13. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
    Brown JM, Hirst DG.
    Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
    [Abstract] [Full Text] [Related]

  • 14. Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazoles.
    Chaplin DJ, Sheldon PW, Ahmed I, Adams GE.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1647-51. PubMed ID: 6480452
    [Abstract] [Full Text] [Related]

  • 15. Modification of alkylating agent induced cell kill by 2-nitroimidazoles in unclamped and clamped SC 9L tumors.
    Wallen CA, Moore SK, Wheeler KT.
    Int J Radiat Oncol Biol Phys; 1992 Sep; 22(4):727-30. PubMed ID: 1531976
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
    Horsman MR, Evans JW, Brown JM.
    Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
    [Abstract] [Full Text] [Related]

  • 17. The in vitro sensitivities to radiation and misonidazole of mouse bone marrow cells derived from different microenvironments.
    Allalunis-Turner J, Chapman JD.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Mar; 49(3):415-22. PubMed ID: 3485590
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the cytotoxicity of 5-thio-D-glucose and misonidazole on hypoxic cells in vitro.
    Song CW, Lee CK, Rhee JG, Levitt SH.
    Int J Radiat Oncol Biol Phys; 1982 Mar; 8(3-4):749-52. PubMed ID: 6809705
    [Abstract] [Full Text] [Related]

  • 19. Enhancing effect of pre-treatment of cells with misonidazole in hypoxia on their response to melphalan in air.
    Smith E, Stratford IJ, Adams GE.
    Br J Cancer; 1982 Jul; 46(1):117-26. PubMed ID: 7104191
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential.
    Mulcahy RT, Dembs NL, Ublacker GA.
    Br J Cancer; 1984 Mar; 49(3):307-13. PubMed ID: 6704305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.